Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology
Bryant Lim, Beth Sproule, Zarin Zahra, et al.
International Clinical Psychopharmacology (2020) Vol. 35, Iss. 5, pp. 243-253
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 304
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Andrew J. Cutler, Gregory W. Mattingly, Vladimir Maletic
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Identifying depression and its determinants upon initiating treatment: ChatGPT versus primary care physicians
Inbar Levkovich, Zohar Elyoseph
Family Medicine and Community Health (2023) Vol. 11, Iss. 4, pp. e002391-e002391
Open Access | Times Cited: 44
Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review
Jaden Brandt, Jolene Bressi, Mê‐Linh Lê, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102507-102507
Open Access | Times Cited: 10
Positive affect and reward processing in the treatment of depression, anxiety and trauma
Michelle G. Craske, Barnaby D. Dunn, Alicia E. Meuret, et al.
Nature Reviews Psychology (2024)
Closed Access | Times Cited: 10
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders
Autumn Walkerly, Lauren D. Leader, Emily Cooke, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3017-3026
Open Access | Times Cited: 41
Dexmedetomidine Inhibits Paraventricular Corticotropin-releasing Hormone Neurons that Attenuate Acute Stress-induced Anxiety-like Behavior in Mice
Gaolin Qiu, Peng Wang, Rao Jin, et al.
Anesthesiology (2024) Vol. 140, Iss. 6, pp. 1134-1152
Closed Access | Times Cited: 5
Influence of β‐catenin signaling on neurogenesis in neuropsychiatric disorders: Anxiety and depression
Rana A. El‐Kadi, Noha F. Abdelkader, Hala F. Zaki, et al.
Drug Development Research (2024) Vol. 85, Iss. 1
Closed Access | Times Cited: 4
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Dina Ali, H. Mokdad Ali, Matthew R. Lopez, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 318-318
Open Access | Times Cited: 4
Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
Feng Huang, Xiao Li San, Qingqian Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Insufficient Evidence to Recommend Shu Mian Capsule in Managing Depression With or Without Comorbid Insomnia: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
Fei-Yi Zhao, Peijie Xu, Gerard A. Kennedy, et al.
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 167-183
Open Access
The Development of GABAergic Network in Depression in Recent 17 Years: A Visual Analysis Based on CiteSpace and VOSviewer
Jieping Lin, Fa Ling, Ping Huang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 16
Distinct mechanisms of allopregnanolone and diazepam underlie neuronal oscillations and differential antidepressant effect
Keiko Takasu, Yosuke Yawata, Ryoichi Tashima, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 3
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Amir Garakani, James W. Murrough, Rafael C. Freire, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2021) Vol. 19, Iss. 2, pp. 222-242
Open Access | Times Cited: 18
Baseline benzodiazepine exposure is associated with greater risk of transition in clinical high-risk for psychosis (CHR-P): a meta-analysis
Andrea Raballo, Michele Poletti, Antonio Preti
Psychological Medicine (2023) Vol. 53, Iss. 14, pp. 6417-6423
Closed Access | Times Cited: 6
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities
Luana M. Manosso, Luciano A. Duarte, Nicoly S. Martinello, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 9, pp. 1085-1100
Closed Access | Times Cited: 6
Efficacy and safety of transcutaneous electrical acupoints stimulation for preoperative anxiety in thoracoscopic surgery: study protocol for a randomised controlled trial
Xindi Wu, Tongyu Chen, Ke Wang, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e067082-e067082
Open Access | Times Cited: 5
Effect of severity of depression on augmentation of antidepressant medication in young adults with depression
Pasi Lampela, Antti Tanskanen, Markku Lähteenvuo, et al.
Acta Psychiatrica Scandinavica (2023) Vol. 149, Iss. 1, pp. 41-51
Open Access | Times Cited: 4
Differential effects of allopregnanolone and diazepam on social behavior through modulation of neural oscillation dynamics in basolateral amygdala and medial prefrontal cortex
Yosuke Yawata, Ryoichi Tashima, Hiroyuki Aritomi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Alprazolam
Harkishan Mamtani, Santosh K. Chaturvedi
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 204-208
Closed Access | Times Cited: 3
Evolving Trends and Economic Burden of Benzodiazepine Use: Insights From a 10-Year Predictive Model
Andro Koren, Luciana Koren, Robert Marčec, et al.
Value in Health Regional Issues (2023) Vol. 40, pp. 70-73
Closed Access | Times Cited: 3
Risk of mortality associated with concomitant antidepressant and benzodiazepine therapy among patients with depression: a population-based cohort study
Han Eol Jeong, Ha‐Lim Jeon, In‐Sun Oh, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Baseline cognitive functioning can predict the trajectory of acute treatment in first-episode major depressive disorder
Sha Liu, Yujie Tong, Xiao Wang, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 5, pp. 1129-1137
Closed Access | Times Cited: 3
Long-term benzodiazepine use and risk of labor market marginalization in Finland: A cohort study with 5-year follow-up
Heidi Taipale, Antti Tanskanen, Terhi Kurko, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access
Phytochemical Evaluation and Screening of Anti-Depressant and Anxiolytic Activities of Bacopa monniera in rats
Vinyas Mayasa, Rebecca Rebecca, Archana S. Patil, et al.
Research Journal of Pharmacy and Technology (2024), pp. 2587-2591
Closed Access
Page 1 - Next Page

Scroll to top